Freeline Therapeutics Holdings plc Annual Depreciation, Depletion and Amortization in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2018 to 2022.
  • Freeline Therapeutics Holdings plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $320K, a 40.9% decline year-over-year.
  • Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2022 was $1.74M, a 27.2% decline from 2021.
  • Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2021 was $2.39M, a 24.9% increase from 2020.
  • Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2020 was $1.91M, a 24.2% increase from 2019.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.74M -$649K -27.2% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 $2.39M +$477K +24.9% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 $1.91M +$373K +24.2% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
2019 $1.54M +$570K +58.8% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 $970K Jan 1, 2018 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.